Skip to main content

Ninepoint Partners Announces May 2026 Cash Distributions for its ETFs and ETF Series Securities

TORONTO, May 22, 2026 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint Partners”) today announced the May 2026 cash distributions for its ETFs and ETF Series securities. The record date for the distributions is May 29, 2026. All distributions are payable on June 5, 2026. The per-unit May 2026 distributions are detailed below:Ninepoint ETF Series Ticker Distribution per unit Notional Distribution per unit CUSIPNinepoint Diversified Bond Fund NBND $ 0.058286 $ 0.000000 65443H100Ninepoint Alternative Credit Opportunities Fund NACO $ 0.099331 $ 0.000000 65443Q100Ninepoint Energy Income Fund NRGI $ 0.222360 $ 0.000000 65444A104Ninepoint Target Income Fund TIF $ 0.082040 $ 0.000000 65446C108Ninepoint Global Infrastructure Fund INFR $ 0.072246 $ 0.000000 65443G102Ninepoint Balanced+ Fund NBAL $ 0.090290 $ 0.000000 65443K103Ninepoint...

Continue reading

REV Closes Deal With Major Gold on Quebec Mining Claims

REV Corporate Video: https://youtu.be/biOHmBtI8ns VANCOUVER, British Columbia, May 22, 2026 (GLOBE NEWSWIRE) — REV Exploration Corp. (“REV” or the “Company”) (TSXV: REVX; OTC: REVFF; FSE: 7FF) is pleased to announce that, further to its February 19, 2026 news release, it has closed the disposition of certain mining claims held by the Company in Quebec (the “Purchased Assets”) (the “Transaction”), pursuant to an asset purchase agreement between the Company and Major Gold Corp. (“MGC”) dated February 19, 2026 (the “Asset Purchase Agreement”) for a purchase price of $1,240,000 of share consideration (the “Purchase Price”). Commenting on the Transaction, Jordan Potts, CEO and Director of REV, stated: “REV is pleased to complete this transaction with Major Gold, which we believe provides a pathway for these assets to continue to be...

Continue reading

Leo International Precision Health AG approves cash capital increase excluding subscription rights

Leo International Precision Health AG / Keyword: Capital measures / Capital increase Leo International Precision Health AG approves cash capital increase excluding subscription rights 22. May 2026 / 20:04 CET/CESTDisclosure of an inside information acc. to Article 17 of the Regulation (EU) No 596/2014, transmitted by GlobeNewswire.The issuer is solely responsible for the content of this announcement.The management board and the supervisory board of Leo International Precision Health AG (ISIN DE0005490601, WKN 549060, ticker symbol LEOW, „Company“) resolved today to increase the Company’s share capital by approximately 4.2 % against cash contributions through the issuance of 24,000 new no-par bearer shares of the Company (“New Shares”), utilizing a portion of the authorized capital 2025 and excluding shareholders’ subscription...

Continue reading

Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1)

Wegovy® 7.2 mg in a single-dose pen has now been recommended by CHMP for approval in the EU Novo Nordisk expects to launch Wegovy® 7.2 mg in a single-dose pen in the EU in Q3 2026 In the STEP UP trial, Wegovy® 7.2 mg demonstrated an average weight loss of 20.7%1, and around one-third of patients achieved 25% or greater weight loss Wegovy® 7.2 mg is already available in the U.S. for adults living with obesity under the brand name Wegovy® HDBagsværd, Denmark, 22 May 2026 – Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing authorisation of Wegovy® 7.2 mg (once-weekly injectable semaglutide 7.2 mg) in a single-dose pen for people living with obesity. Wegovy® 7.2 mg is already available in the EU for...

Continue reading

Ninepoint Partners Announces Estimated May 2026 Cash Distributions for Ninepoint Cash Management Fund – ETF Series

TORONTO, May 22, 2026 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint Partners”) today announced the estimated May 2026 cash distribution for the ETF Series of Ninepoint Cash Management Fund (the “Fund”). Ninepoint Partners expects to issue a press release on or about May 28, 2026, which will provide the final distribution rate. The record date for the cash distribution is May 29, 2026, payable on June 5, 2026. All estimates in this document are based on the accounting data as of May 21, 2026. Due to subscriptions and/or redemptions and/or other factors, the final May 2026 distribution may differ from these estimates and the difference could be material. The information included in this letter is for reference purposes only. Please reconcile all information against your official client statements. This is not intended to be...

Continue reading

NevGold Congratulates Perpetua Resources On US$2.9 Billion Loan for the Gold-Antimony Stibnite Project in Idaho; NevGold Rapidly Advancing its At-Surface Oxide, Antimony-Gold Limo Butte Project to Near-Term U.S. Production

Vancouver, British Columbia, May 22, 2026 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) congratulates Perpetua Resources Corp. (TSX:PPTA, NASDAQ:PPTA, “Perpetua”) on the approved US$2.9 billion senior secured project loan from the Export-Import Bank of the United States (“EXIM”) (see Perpetua Resources News Release from May 21, 2026) under the “Make More in America Initiative”. The loan supports the development of the Stibnite gold‑antimony project in Idaho and represents a major commitment by the U.S. Government to rebuilding a secure domestic antimony supply chain. Perpetua’s Stibnite Project is currently the only large-scale, domestic resource of the Critical Mineral antimony. NevGold is rapidly advancing its maiden antimony-gold Mineral Resource Estimate (“MRE”) at the...

Continue reading

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

PALO ALTO, Calif., May 22, 2026 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its board of directors (the “Board”) approved a dividend of Semnur Pharmaceuticals, Inc. (“Semnur”) (OTC: SMNR) common stock held by the Company to its stockholders and certain other eligible equityholders of Scilex (collectively, the “Participating Holders”). The record date for the dividend is June 1, 2026 (the “Record Date”). The Participating Holders as of the Record Date will be entitled to receive one (1) share of common stock of Semnur for each share of Scilex common...

Continue reading

MEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE)

Medx Holdings Inc Name Change to Dazed Inc and Lazydaze Coffeeshop Franchise 2026 Summer of Growth Austin, Texas, May 22, 2026 (GLOBE NEWSWIRE) — MEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE) AUSTIN, Texas — May 22, 2026 — MedX Holdings, Inc. (OTC: MEDH), a leader in the converging cannabis, hemp, and hospitality sectors, today announced its operational and financial highlights for the first quarter of 2026. Building on the net profitability achieved in Q4 2025, the company continues to execute its aggressive expansion strategy, marked by upcoming store openings, strategic product partnerships, and a major corporate rebranding initiative to align with its rapidly growing consumer footprint. Corporate Action: Rebranding to Dazed Inc. To align the company’s...

Continue reading

Agreement for a new NOK 155 million order for GNSS On-Board Unit deliveries

NORBIT today announces that its segment Connectivity has entered into an agreement regarding a new order for deliveries to the leading European Electronic Toll Service (EETS) provider Toll4Europe of GNSS On-Board Units. Deliveries are scheduled to commence in third quarter. The total order is estimated to around NOK 155 million. “We are grateful for the continued trust from Europe’s leading tolling service provider. This repeat order reflects the strength of our long-term partnership”, says Per Jørgen Weisethaunet CEO of NORBIT.  For further queries, please contact:Per Jørgen Weisethaunet, CEO, +47 959 62 915Per Kristian Reppe, CFO, +47 900 33 203 About NORBIT ASANORBIT is a global provider of tailored technology to selected applications, solving challenges and promoting sustainability through innovative solutions, in line with its mission...

Continue reading

Stoneshield Capital to acquire 15% stake in Exolum from OMERS

LUXEMBOURG, May 22, 2026 (GLOBE NEWSWIRE) — Stoneshield Capital today announced that it has signed an agreement to acquire a 15% stake in Exolum from OMERS, building on its existing investment in the company since January 2026. The remaining 10% of OMERS ~25% stake is separately being acquired by a leading global investment firm with over $100 billion in assets under management. OMERS, together with its investment partners, has been invested in Exolum since 2016. Terms of the transactions are not being disclosed. Exolum is a Spanish-headquartered global energy logistics company specialising in the transportation, storage and distribution of refined products, bulk liquids and aviation fuels, while playing an increasingly important role in supporting the energy transition. Exolum owns a 4,000km transmission pipeline network in Spain...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.